Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C Academic Article uri icon

Overview

MeSH Major

  • Antiviral Agents
  • Cognition
  • Hepatitis C, Chronic
  • Interferon-alpha
  • Polyethylene Glycols
  • Ribavirin

abstract

  • Retreatment of prior non-responders with peginterferon and ribavirin was not associated with objective evidence of cognitive impairment as measured by a comprehensive battery of neuropsychological tests. The lack of cognitive impairment is reassuring and suggests that self-reported symptoms of cognitive dysfunction are more likely related to the systemic and psychiatric side effects of antiviral treatment rather than measurable changes in cognition.

publication date

  • May 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/hep.21633

PubMed ID

  • 17465000

Additional Document Info

start page

  • 1154

end page

  • 63

volume

  • 45

number

  • 5